Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-01

Clinical Trial Update: Urinary Biomarkers For Objective Measurement Of InterStim® Response In Over Active Bladder (OAB) Patients.

View source ↗

Summary

An update on a completed clinical trial investigating urinary biomarkers to objectively measure responses to InterStim sacral neuromodulation in patients with o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • InterStim

Snippet

Sponsor: Michael Chancellor, MD | Conditions: Overactive Bladder | Status: COMPLETED